Lawmakers are being asked to modernize the FDA's regulatory framework.
Steady: 0 in the last 7 days
Updated sep 15
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lawmakers are being asked to modernize the FDA's regulatory framework.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The FDA stated its intent to modernize regulatory processes to maintain leadership.Sub-event
- Buddy Carter led legislation and Vern Buchanan supported a bill aimed at modernizing FDA testing methods.Sub-event
- FDA approval status impacts drug market access.Sub-event
Call for modernization of FDA's regulatory framework by lawmakers.1 source
Keep exploring
The entities involved
Related events
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
- Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.
- MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.
- Congress introduced AI legislation, CMS expanded value-based models, FDA built AI infrastructure, and FTC rescinded a health data breach policy.
- FDA policy proposal affects the operations of AI, Inc.